Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The hERG channel, encoded by the KCNH2 gene, is a voltage-gated potassium ion channel crucial for cardiac action potential repolarization. Dysfunction, either through mutations or drug blockade, leads to Long QT Syndrome (LQTS) and potentially fatal arrhythmias like torsades de pointes. Its susceptibility to blockade by a wide range of drugs poses significant safety concerns during drug development.
hERG channel blockade
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human Ether-à-go-go-Related Gene potassium channel (hERG).